$USB

TD Cowen resumes coverage of U.S. Bancorp with Buy rating, $70 price target

TD Cowen resumed coverage of U.S. Bancorp with a Buy rating and $70 price target, implying a 22.7% upside from the Oct 8 close. The bank's strong profitability, revenue growth, and diversified services support the positive outlook, according to the analyst note.

Original reporting
Published Oct 9, 2026, 10:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 10:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen resumes coverage of U.S. Bancorp with Buy rating, $70 price target — source image
Decision brief

The 30-second read

$USBBullishMed
01

Why it matters

The new Buy rating and $70 target imply a 22.7% upside from the recent close.

02

Market read

Analyst upgrade could drive short‑term buying interest in USB.

03

What to watch

Potential regulatory or credit risk concerns not addressed in the note.

Relevance 7/10Novelty 6/10Timing: today

Background

TD Cowen had previously discontinued coverage; reinstating it signals renewed confidence.

Company-level read

Ticker impact

$USBBullishMedium confidence
Context

TD Cowen reinstated coverage on U.S. Bancorp with a Buy rating and a $70 price target.

Expected impact

likely upward pressure as investors price in the new target.

Evidence & confidence

The coverage reinstatement is a fresh analyst action with a concrete target, indicating a bullish outlook.

Market effects

Positive sentiment may spill over to other regional banks and financial services firms.

U.S. banking sector could see modest uplift in the short term.

Limited to U.S. financial markets; no broader macro impact.

Counterpoint

The upgrade may be premature if macro pressures on banks intensify.

Key entities

  • TD Cowen

    Research analyst firm that reinstated coverage.

  • U.S. Bancorp

    Banking institution receiving the coverage upgrade.

Related articles

$USBMed

US Bancorp (USB) Gets a Buy from Oppenheimer

Oppenheimer maintained a Buy rating on US Bancorp (USB) with a $72.00 price target. Truist Financial also issued a Buy, while J.P. Morgan kept a Hold. USB reported Q2 revenue of $10.92B and net profit of $2.18B, up from last year. Insider sentiment is negative, with recent sales by executives.

$USBMed

USB Maintains Rating by Evercore ISI Group -- Price Target Lower

Evercore ISI Group maintained an 'Outperform' rating on U.S. Bancorp (USB) but lowered its price target from $72.00 to $65.00, citing market conditions. USB's GF Value™ is $51.30, suggesting a 9.3% overvaluation. The company's GF Score™ is 84, indicating strong performance but with lower financial strength. Insider activity shows significant selling.

$USBMed

US Fed plans to raise bank oversight thresholds, sources say

The US Federal Reserve plans to raise asset thresholds for stricter oversight of big banks, according to sources. Current thresholds are $100B, $250B, and $700B. The Fed may reindex these, potentially benefiting banks like U.S. Bancorp, Capital One, and PNC Financial. Changes could spur consolidation among mid-size lenders and increase competition, but critics argue it may reduce consumer benefits and increase systemic risks.

$JPMHigh

Banks Lift Prime Rate to 7% as Fed Launches First Tightening Move Since 2023

Major U.S. banks, including JPMorgan, Bank of America, and Citigroup, raised their prime lending rates to 7% following the Federal Reserve's quarter-point increase in the federal funds rate to 3.75%-4%. The Fed cited persistent inflation. Bank stocks fell, reflecting mixed investor sentiment. The Fed projects further rate hikes, with implications for borrowers and the broader economy.